My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status.

    Zhu Y, Brown HN, Zhang Y, Holford TR, Zheng T.

    Breast Cancer Res. 2005;7(5):R745-52. Epub 2005 Jul 19.PMID: 16168120 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

    Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.

    BMC Cancer. 2005 Jul 19;5:81.PMID: 16029503 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.

    Wedrén S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvänen AC, Kindmark A, Landegren U, Fermér ML, Stiger F, Persson I, Baron J, Weiderpass E.

    Breast Cancer Res. 2004;6(4):R437-49. Epub 2004 Jun 4.PMID: 15217512 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

    Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249. PMID: 16807674 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

    Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I.

    Carcinogenesis. 2003 Sep;24(9):1533-9. Epub 2003 Jul 4.PMID: 12844487 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.

    Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M.

    Breast Cancer Res. 2008;10(4):R57. Epub 2008 Jul 8.PMID: 18611262 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.

    Talbott KE, Gammon MD, Kibriya MG, Chen Y, Teitelbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H.

    Breast Cancer Res Treat. 2008 Oct;111(3):481-7. Epub 2007 Nov 2.PMID: 17975727 [PubMed - indexed for MEDLINE]Related articles

    8.

    IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.

    Slattery ML, Curtin K, Baumgartner R, Sweeney C, Byers T, Giuliano AR, Baumgartner KB, Wolff RR.

    Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):747-55.PMID: 17416766 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

    Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A.

    Breast Cancer Res. 2005;7(6):R987-97. Epub 2005 Oct 11.PMID: 16280050 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

    Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

    Breast Cancer Res. 2008;10(2):R31. Epub 2008 Apr 17.PMID: 18419802 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.

    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.

    Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1090-5.PMID: 15894657 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.

    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.

    Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1290-5.PMID: 15298948 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Genetic variation in TP53 and risk of breast cancer in a population-based case control study.

    Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.

    Carcinogenesis. 2007 Aug;28(8):1680-6. Epub 2007 Apr 21.PMID: 17449902 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.

    Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W.

    Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1148-52.PMID: 16775174 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.

    Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.

    Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):821-5.PMID: 15824150 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

    Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Brüning T, Brauch H.

    Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2059-64.PMID: 15598761 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.

    Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, Wang Y, Tang J, Wang H, Shen H.

    Carcinogenesis. 2008 Dec;29(12):2341-6. Epub 2008 Oct 8.PMID: 18845558 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.

    McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE.

    Breast Cancer Res. 2007;9(1):R9.PMID: 17244366 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

    Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

    BMC Med Genet. 2007 Dec 1;8:72.PMID: 18053149 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.

    Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S.

    Int J Cancer. 2007 Dec 1;121(11):2532-8.PMID: 17683073 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk